Innovation toward conquering human diseases

I’m pleased to introduce our company to you eventually.

Innovo Therapeutics is a biotech company established by multiple experts with more than 20 years of experience in new drug development, focusing on NCE (new chemical entity) discovery.

Our goal is to develop new drugs for patients suffering from intractable diseases such as idiopathic pulmonary fibrosis, osteoarthritis, ulcerative colitis, etc.

Our primary research field is fibrosis, inflammation, immunology and oncology.

Innovo has developed DeepZema®, an AI-augmented drug development platform, with all our efforts because we acknowledge how critical minimizing errors and increasing success rates in the new drug development process is. In addition, the expertise of the research faculty leads to the acceleration of R&D projects.

Our fundamental objective of starting a new company was centered around caring for patients. This will never change. We always do our best to make our development outcomes ready for patients in the market as fast as possible.

We, employees of Innovo Therapeutics, want to share our promise to be the leading bio-company shortly, keeping a high level of our contribution to human health & life.

Thank you,